Origin Bio

Origin Bio is a cancer-biology research company that generates spatial, molecular, and functional maps from patient tumor samples to study cancer in its native tissue context. Its platform combines a spatial genomics pipeline that maps gene expression while preserving tissue architecture, tissue phenotyping that grounds molecular findings in histology and protein measurements, and functional response testing that runs ex vivo drug and perturbation experiments on precision-cut tumor slices. On top of this proprietary sequencing and spatial-transcriptomics data the company trains multimodal AI models for therapeutic target discovery, treatment-response prediction, and patient stratification. Origin Bio is a Y Combinator (Winter 2026) company. As of this profile the company publishes no public-facing API, developer documentation, or SDKs; this record is maintained in the API Evangelist network as a company profile.

Origin Bio is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Cancer Research, Spatial Genomics, and Transcriptomics.

🌐 Visit website 📡 Source on GitHub
7.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyBiotechnologyCancer ResearchSpatial GenomicsTranscriptomicsArtificial IntelligenceLife SciencesY Combinator

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 7.7/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.0 / 20
Commercial Clarity 0.0 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/origin-bio: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Origin Bio Domain Security

TLSv1.3

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Company 1

The organization behind the API

Website
Website

Other 1

Properties that don't map to a standard resource type

Company
Company

Source (apis.yml)

apis.yml Raw ↑ 
aid: origin-bio
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/origin-bio.png
name: Origin Bio
description: Origin Bio is a cancer-biology research company that generates spatial, molecular, and functional maps from patient
  tumor samples to study cancer in its native tissue context. Its platform combines a spatial genomics pipeline that maps
  gene expression while preserving tissue architecture, tissue phenotyping that grounds molecular findings in histology and
  protein measurements, and functional response testing that runs ex vivo drug and perturbation experiments on precision-cut
  tumor slices. On top of this proprietary sequencing and spatial-transcriptomics data the company trains multimodal AI models
  for therapeutic target discovery, treatment-response prediction, and patient stratification. Origin Bio is a Y Combinator
  (Winter 2026) company. As of this profile the company publishes no public-facing API, developer documentation, or SDKs;
  this record is maintained in the API Evangelist network as a company profile.
url: https://raw.githubusercontent.com/api-evangelist/origin-bio/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- y-combinator
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Biotechnology
- Cancer Research
- Spatial Genomics
- Transcriptomics
- Artificial Intelligence
- Life Sciences
- Y Combinator
apis: []
common:
- type: DomainSecurity
  url: security/origin-bio-domain-security.yml
- type: Website
  url: https://origin.bio/
- type: Company
  url: https://www.ycombinator.com/companies/origin-bio
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-20'
  status: minimal
  artifacts_added: 1
  pass: local-v1